Formula Shortage Reporting Act of 2022

Hozzl · 2022-12-29T17:18:47Z

Explore the details of House Bill 8038 Formula Shortage Reporting Act of 2022 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/29/2022, 5:18 PM

Summary of Bill HR 8038

Bill 117 hr 8038, also known as the Formula Shortage Reporting Act of 2022, is a piece of legislation introduced in the US Congress. The purpose of this bill is to address the issue of formula shortages in the United States.

The bill requires manufacturers of infant formula to report any shortages of their products to the Food and Drug Administration (FDA) within 30 days of becoming aware of the shortage. This reporting requirement aims to improve transparency and communication between manufacturers and the FDA in order to better address and resolve formula shortages in a timely manner.

Additionally, the bill requires the FDA to publish information on formula shortages on its website, including the cause of the shortage, the expected duration, and any actions being taken to address the shortage. This information will be updated regularly to keep the public informed about the status of formula shortages in the US. Overall, the Formula Shortage Reporting Act of 2022 seeks to improve the availability of infant formula in the United States by requiring manufacturers to report shortages to the FDA and increasing transparency around the issue. This legislation aims to ensure that parents and caregivers have access to the formula they need to properly nourish their infants.

Congressional Summary of HR 8038

Formula Shortage Reporting Act of 2022

This bill requires manufacturers of infant formula to notify the Food and Drug Administration (FDA) at least 72 hours in advance of a manufacturing interruption or product discontinuance that is expected to meaningfully disrupt the product's supply. The FDA must post such information on its website and notify health care providers.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 8038

Bill HR 8038 is currently in the status of Bill Introduced since June 13, 2022. Bill HR 8038 was introduced during Congress 117 and was introduced to the House on June 13, 2022. Bill HR 8038's most recent activity was Referred to the House Committee on Energy and Commerce. as of June 13, 2022

Bipartisan Support of Bill HR 8038

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 8038

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 8038

Formula Shortage Reporting Act of 2022

To authorize the Food and Drug Administration to require manufacturers of infant formula to warn about a discontinuance or interruption in the production of infant formula, and for other purposes.